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Induction of TNF Receptor I-Mediated Apoptosis
via Two Sequential Signaling Complexes
of these receptors delivers a powerful and rapid proapo-
ptotic signal through a DD-mediated recruitment of the
adaptor protein FADD and the formation of the so-called
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death-inducing signaling complex (DISC) (Scaffidi et al.,BIL Biomedical Research Center
1999). FADD in turn, via its death effector domain (DED),Chemin des Boveresses 155
mediates the recruitment and the activation of procas-CH-1066 Epalinges
pase-8, leading to the release of the active p18/p12Switzerland
fragments. Cytoplasmic caspase-8 then activates down-
stream caspases that participate in the execution of
the apoptotic process. Recruitment of FLIP to the DISCSummary
inhibits the release of the active caspase-8 fragments
from the complex (Irmler et al., 1997) and thus blocksApoptosis induced by TNF-receptor I (TNFR1) is
cell death.thought to proceed via recruitment of the adaptor
In contrast to Fas and TRAIL-receptors, the molecularFADD and caspase-8 to the receptor complex. TNFR1
mechanisms involved in TNFR1-induced cell death re-signaling is also known to activate the transcription
main poorly defined, despite the fact that signalingfactor NF-B and promote survival. The mechanism
through TNFR1 has long been studied (Chen and Goed-by which this decision between cell death and survi-
del, 2002; Rath and Aggarwal, 1999). It is currently be-val is arbitrated is not clear. We report that TNFR1-
lieved that engagement of TNFR1 triggers the recruit-induced apoptosis involves two sequential signaling
ment of the DD-containing adaptor molecule TRADDcomplexes. The initial plasma membrane bound com-
followed by the DD-containing Ser/Thr kinase RIP1 (Ash-plex (complex I) consists of TNFR1, the adaptor TRADD,
kenazi and Dixit, 1998; Chen and Goeddel, 2002). Thisthe kinase RIP1, and TRAF2 and rapidly signals activa-
signaling complex is required for TRAF2/5 and c-IAP1tion of NF-B. In a second step, TRADD and RIP1 associ-
binding that leads to the triggering of NF-B and JNKate with FADD and caspase-8, forming a cytoplasmic
signaling pathways (Baud and Karin, 2001). TNFR1 oc-complex (complex II). When NF-B is activated by com-
cupation not only triggers these pathways, but can alsoplex I, complex II harbors the caspase-8 inhibitor FLIPL
induce apoptosis by instead binding the DD-containingand the cell survives. Thus, TNFR1-mediated-signal
adaptor FADD (via TRADD) that allows caspase-8 re-transduction includes a checkpoint, resulting in cell
cruitment and activation (Hsu et al., 1996). In an alterna-death (via complex II) in instances where the initial
tive, though not exclusive model, the initial TRADD-RIP1signal (via complex I, NF-B) fails to be activated.
containing complex has been proposed to bind the
adaptor protein RAIDD, resulting in caspase-2 depen-Introduction
dent cell death activation (Duan and Dixit, 1997). How-
ever, both models are based on studies where inter-
Tumor necrosis factor (TNF) is a potent cytokine that
action was demonstrated upon massive overexpression
exerts pleiotropic functions in immunity, inflammation, of proteins putatively present in the signaling complex
control of cell proliferation, differentiation, and apopto- and has yet to be confirmed under physiological condi-
sis (Ashkenazi and Dixit, 1998; Wallach et al., 1999). TNF tions. Indeed, caspase-2 appears to be dispensable for
is the prototypical member of a still growing family of TNF-induced apoptosis (Lassus et al., 2002). In contrast
cytokines that include, among others, TNF, lympho- there is genetic evidence that FADD and caspase-8 are
toxin- (LT), Fas ligand (FasL), CD40 ligand (CD40L), important for TNFR1-mediated apoptosis (Juo et al.,
and TNF-related apoptosis-inducing ligand (TRAIL). Al- 1998; Yeh et al., 1998). Moreover, expression of the
though most of the TNF family members are potent inhibitor of caspase-8, FLIPL, inhibits the TNF-induced
inducers of the signaling pathways that lead to the acti- apoptotic pathway (Micheau et al., 2001), further arguing
vation of the transcription factor NF-B, some of these for an important role of caspase-8. FLIPL expression is
ligands can also induce apoptosis by binding to so- induced by NF-B (Kreuz et al., 2001; Micheau et al.,
called death receptors. These receptors (TNFR1, Fas 2001), which may explain why death receptor-induced
[CD95], TRAMP [DR3], TRAIL-R1 [DR4], TRAIL-R2 [DR5], apoptosis is generally blocked in cells with active NF-B.
DR6, and EDAR) share not only the typical amino-termi- Here we demonstrate that, unlike the Fas signaling path-
nal cysteine-rich domains (CRDs), which define their way, the TNFR1-induced proapoptotic signaling pathway
ligand specificity (Bodmer et al., 2002), but also a stretch requires the formation of two distinct signaling complexes.
of 60–70 amino acids called the death domain (DD) that The rapidly formed plasma membrane bound complex I
is necessary for the induction of apoptosis (Ashkenazi is composed of TNFR1, TRADD, RIP, TRAF2, and c-IAP1
and Dixit, 1998). and triggers a NF-B response, but no apoptosis. A
Signaling through Fas, TRAIL-R1 and TRAIL-R2 has second complex, which lacks TNFR1 but includes FADD
been well characterized (Krammer, 2000). Engagement and procaspases-8 and -10, subsequently forms in the
cytoplasm. This secondary complex (complex II) initi-
ates apoptosis, provided that the NF-B signal from*Correspondence: jurg.tschopp@ib.unil.ch
complex I fails to induce the expression of antiapoptotic2 Present address: INSERM U517, Faculties of Medicine and Phar-
macy, 7 Boulevard Jeanne d’Arc, 21033 Dijon Cedex, France. proteins such as FLIPL.
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Results
TNFR1 Triggers Apoptosis in the NF-B
Unresponsive HT1080 I-kBmut Cells
NF-B can promote the expression of several antiapo-
ptotic genes such as TRAF1, TRAF2, cIAP-1, c-IAP-2,
and notably FLIPL, a potent inhibitor of death receptor-
induced apoptosis (Micheau et al., 2001; Wang et al.,
1998). We previously described the HT1080 fibrosar-
coma cell line that is proficient in NF-B activation (des-
ignated wt) and a variant of this cell line (designated
IBmut) that is defective in NF-B activation to the ex-
pression of an undegradable form of the NF-B inhibitor
I-B (Micheau et al., 2001). NF-B-induced upregula-
tion of antiapoptotic proteins protects the former but
not the latter cell line from TNF-induced apoptosis (Mi-
cheau et al., 2001) (Figure 1A). Determination of cas-
pase-3 activity demonstrated that TNF-induced apopto-
sis was slow and detectable only 4 hr after TNF addition,
and that it involved processing of caspase-8, caspase-3,
and caspase-2 (Figure 1B). Inhibition of the apoptotic
process was achieved with zVAD-fmk (Figure 1B) at
concentrations as low as 5 M. Moreover, TNF-induced
cell death was specifically inhibited by an antagonistic
anti-TNFR1 but not anti-TNFR2 antibody in a concentra-
tion-dependent manner (Figure 1C), indicating that cell
death was mediated by TNFR1.
The TNFR1-Membrane-Associated Proximal
Complex (Complex I) Is Devoid of Caspase-8
and FADD
In an attempt to define the molecular mechanisms which
govern the cell’s decision to activate NF-B or, alterna-
tively, to undergo cell death, the composition of the
signaling complexes in HT1080-wt and HT1080-IBmut Figure 1. TNFR1 Induces Slow Apoptosis in the NF-B Unrespon-
cells was initially investigated. Using a Flag-tagged re- sive HT1080 I-kBmut Cells
combinant human TNF (Figure 2A), Fc-TNF (Figure 2B), (A) The HT1080 fibrosarcoma cell lines, wt (circles) or I-Bmut (stably
or a specific anti-TNFR1 antibody (data not shown), we transfected with a mutated, nondegradable version of IB, squares)
found no obvious divergence in protein composition of were treated with increasing quantities of TNF and cell viability
assessed after 48 hr.the precipitated signaling complex (complex I) obtained
(B) Wt or I-Bmut HT1080 cells were treated with 50 ng/ml TNF forfrom either cell line. In the wt as well as in the I-B mutant
the indicated period of time, in the presence or absence of 50 Mcells, RIP1, TRAF2, and the adaptor protein TRADD were
zVAD-fmk. Cell extracts were analyzed for caspase-8, caspase-2,
coimmunoprecipitated with TNFR1 (Figures 2A and 2B). and caspase-3 content by Western blotting. Caspase-3 activity was
Notably, c-IAP1 was primarily found in the signaling quantified in wt (empty bars) and I-Bmut (filled bars) cells by use
complex of TNF resistant but not sensitive cells. This of the substrate DEVD-AMC.
(C) TNF-induced apoptosis of HT1080 I-Bmut cells is mediated byfinding is in agreement with the proposed role as an
TNFR1. Apoptosis was quantified 24 hr after TNF treatment, in cellsinhibitor of TNF-mediated apoptosis (Wang et al., 1998).
preincubated or not (1 hr) with TNFR1 or TNFR2-antagonistic anti-During the course of stimulation (30 min), a progressive
bodies.
and substantial loss in TNFR1-associated proteins was
observed in both cell lines. A moderate reduction of
TNFR1 binding to the ligand was also observed, proba-
cell line (Figures 2A and 2B), in which cleavage andbly due to endocytosis of the engaged receptor (Schutze
activation of caspase-8 clearly occurred (see Figure 1B).et al., 1999). As previously shown for RIP1 (Zhang et
Likewise, RAIDD and caspase-2 were not found in theal., 2000), TRADD and TNFR1 also underwent extensive
complex (data not shown). FADD and caspase-8 were,posttranslational modifications in complex I. These
however, readily detectable in Fas ligand immunopre-changes were not observed in total cell lysates and were
cipitates of both cell lines, using the same experimentaldetectable by independently raised antibodies (Figures
protocol (Figure 2C and data not shown). Identical data2A and 2B). Ubiquitination is one of the modifications
were obtained with Jurkat and U937 cells, which hadof RIP1 and TNFR1 (Legler et al., 2002), while the nature
been rendered sensitive to TNF-induced cell death byof the extensive TRADD modifications remains to be
use of cycloheximide (not shown), suggesting that thedetermined.
FADD/caspase-8 interaction with complex I is eitherSurprisingly, neither FADD nor caspase-8 was detect-
able in complex I, even in the death-sensitive I-kBmut very weak or does not occur at all.
TNFR1-Induced Apoptosis
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Figure 2. The TNFR1-Membrane-Associated
Complex I Is Devoid of Caspase-8 and FADD
(A) Time course of recruitment of the proximal
signaling complex (complex I) to TNFR1. Wt
or I-kBmut HT1080 cells were stimulated for
the indicated time with Flag-tagged human-
TNF at 37C and immunoprecipitated using
anti-Flag antibodies. Samples were analyzed
by Western blotting using antibodies directed
against TNFR1, TRADD, RIP1, TRAF2, FADD,
caspase-8, or c-IAP1. Cellular extracts (CE)
are shown that correspond to 1/200th of the
cell lysate that was used to perform the immu-
noprecipitation. The filled arrowheads point
to cleaved proteins.
(B) TNFR1-membrane associated complex I
was analyzed as above using a modified ver-
sion of human recombinant TNF fused to the
Fc portion of human IgG1. Where indicated
(0), TNF was added to untreated cell lysates
before immunoprecipitation. Modified pro-
teins are indicated with open arrowheads.
(C) FADD and caspase-8 recruitment to the
Fas DISC was analyzed as above (A) in
HT1080 I-Bmut cells 5 and 15 min after the
addition of Flag-tagged FasL.
TNF Stimulation Triggers the Formation of RIP1, TRADD, and TRAF2 16 hr after TNF stimulation.
Together with the observation that neither caspase-3Complexes of High Molecular Weight
TNFR1 stimulation leads not only to the recruitment and nor Fas partitioned in these high molecular mass frac-
tions upon stimulation (Figure 3), these data suggestassembly of TRADD, RIP1, and TRAF2, but also of com-
ponents of the downstream NF-B machinery, such as that a long-lived complex (designated complex II), com-
prising most of the components of complex I exceptI-B, the protein kinases IKK, , and the scaffold pro-
tein IKK (NEMO) (Poyet et al., 2000; Zhang et al., 2000). TNFR1, is formed.
IKKs assemble in a complex with a molecular mass of
approximately 700 kDa (Karin and Lin, 2002). Complex Evidence for a Caspase-8 and FADD-Containing
Complex IIformation correlates with the activation of the two ki-
nases that act on their I-B substrate. We therefore Upon TNF binding, TNFR1 is internalized (Schutze et al.,
1999). Indeed, in our experimental system, a decrease inanalyzed the size of signaling complexes formed in the
HT1080-IBmut cells. Examination of the elution profile TNFR1 surface accessibility was observed in both wt
or I-kBmut cells upon TNF stimulation (see Figure 2,of proteins following TNF stimulation for 5 min indicated
that the IKKs were present in a high apparent molecular also assessed by flow cytometry, not shown). However,
the moderate loss of surface expression only partly cor-weight complex of approximately 700–1200 kDa as ex-
pected (Figure 3). Interestingly, a proportion of TNFR1, related with the loss of TNFR1-associated proteins ob-
served in Figure 2, suggesting that these proteins disso-RIP1, TRADD, and TRAF2 were also present in a high
mw complex (Figure 3). Sixteen hrs after stimulation, ciate from TNFR1. FADD and caspase-8 were previously
shown to be essential for TNF-mediated cell death (JuoIKK, TNFR1, and to a lesser extent TRADD, TRAF2,
and RIP1 returned to an elution peak indicative of the et al., 1998; Yeh et al., 1998). Both proteins are also
constituents of a high molecular weight complex, whichstatus observed in untreated cells. Analysis of the elu-
tion profiles of caspase-8, capsase-10, and FADD is formed upon TNFR1 engagement (Figure 3). We there-
fore decided to further investigate the putative proapo-proved particularly interesting. These proteins also rap-
idly shifted to high molecular weight after TNF stimula- ptotic complex further downstream in the signaling
pathway, by immunoprecipitating caspase-8. In bothtion, but in contrast to IKK, a substantial portion re-
mained in a complex even after 16 hr. This is consistent resistant wt- and sensitive HT1080-I-Bmut cells stimu-
lated with TNF, caspase-8 immunoprecipitates werewith the observation that caspase-8, capsase-10, and
FADD were not associated with immunoprecipitated found to incorporate not only FADD, but also TRADD,
RIP1, and TRAF2 in a time- and stimulation-dependentTNF-complexes (see Figure 2). In addition, a proportion
of caspase-8, capsase-10, and FADD coeluted with manner (Figure 4A). Association started 30 to 60 min
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the differences in levels of the long form of FLIP (FLIPL)
found in complex II. Higher levels of FLIPL were detect-
able in resistant cells. Importantly, FLIPL was predomi-
nantly found in its uncleaved form in resistant cells, in
contrast to sensitive cells where caspase-8 associated
FLIPL was almost completely processed to produce its
43/41 kDa cleavage products. It has been shown pre-
viously that complete processing of FLIPL occurs only
in cells that undergo apoptosis (Tschopp et al., 1998).
Complex II of resistant but not sensitive cells also con-
tained TRAF1 and c-IAP1, which is expected as TRAF1
and c-IAP-1 expression are dependent on NF-B signals
(Wang et al., 1998). Remarkably, however, TNFR1 was
absent from this secondary complex in both cell lines
(Figure 4A). To make sure that the protocol used to
immunoprecipitate the signaling complex with caspase-8
permitted precipitation of the receptors, it was applied
to cells that had been stimulated with Fas ligand. In
this case, caspase-8 immunoprecipitates revealed an
association with Fas in addition to FADD and FLIPL (Fig-
ure 4B), demonstrating the validity of the method used
and reinforcing the differences in the signaling behavior
of Fas and TNFR1.
To corroborate these data, we investigated the com-
position of complex II 16 hr after stimulation, at a time
when almost all cells had undergone apoptosis. At this
late stage, the composition of complex II in wt and
I-kBmut cells was definitely different. In wt cells, FLIPL
and TRAF-1 were still associated with caspase-8, but
little caspase-10 was coimmunoprecpitated (Figure 5).
In the sensitive HT1080-I-kBmut cell line however, little
or no TRAF1 was present in complex II, and FLIPL was
not detectable at all. In contrast, caspase-10 was abun-
dant and was immunoprecipitated in its processed form.
These data suggested that recruitment of FLIPL andFigure 3. RIP1, TRADD, TRAF2, IKK, FADD, and Caspase-8 Exhibit
caspase-10 to complex II are mutually exclusive. ToHigh Apparent Molecular Weights after TNF Stimulation
corroborate this notion, we expressed FLIPL in sensitiveI-kBmut HT1080 cells were stimulated or not for 5 or 960 min with
I-kBmut cells at a level comparable to that found inTNF, and subsequently lysed in CHAPS lysis buffer. After fraction-
wt cells (Figure 5), which rendered these cells againation on a S200 gel filtration column, TNFR1, RIP1, TRADD, TRAF2,
IKK, caspase-3, caspase-8, caspase-10, FADD, and Fas protein resistant to TNF-mediated apoptosis (data not shown).
content was analyzed by Western blotting. The elution position of While FLIPL levels in complex II were high in these trans-
molecular weight markers (in kDa) are indicated at the top of the fected cells, the amount of caspase-10 was again low.
figure.
Moreover, we overexpressed caspase-8 and caspase-
10 in 293T cells and found that caspase-8 was present
in caspase-10 immunoprecipitates (Figure 5B). Co-poststimulation, increased over time, and was strongest
expression of FLIPL reduced caspase-8 association inafter 4 to 8 hr, corresponding to the time of onset of
a dose-dependent manner, indicating that caspase-8apoptosis (Figure 4A). Association of TRADD and RIP1
and caspase-10 interaction can be modulated by FLIPL.coincided with their disappearance from the primary
complex, suggesting that TRADD and RIP1 dissociated
from complex I. This notion is supported by the observa- TNF-Induced Signaling Complex I and Complex II
Localize to Different Subcellular Compartmentstion that both RIP1 and TRADD carried higher molecular
weight modifications that are induced upon TNFR1 bind- In order to determine the subcellular localization of the
TNFR1 complexes I and II, respectively, cell fraction-ing (see Figure 2). Most importantly, analysis of the
caspase-8 coimmunoprecipitates revealed differences ation experiments prior to immunoprecipitation of
TNFR1 or caspase-8 were performed. HT1080 I-Bmutbetween the resistant and sensitive cell lines. RIP1,
TRADD, and TRAF2 recruitment to caspase-8 was tran- cells were first treated with TNF for different time peri-
ods, and then disrupted by hypotonic lysis. Membranesient in resistant cells, peaking 2–4 hr after TNF stimula-
tion. In contrast, these three proteins remained associ- enriched and soluble fractions were separated by high-
speed centrifugation, and complex I and complex II im-ated with caspase-8 even 8 hr poststimulation in the
sensitive cell line. In addition, both caspase-8 and cas- munoprecipitated after detergent solubilization of the
two fractions. As expected, assembly of complex I oc-pase-10 were cleaved and activated in complex II of the
sensitive cell line, whereas substantially less processing curred principally in the membrane enriched P100 (pel-
let) fraction (Figure 6A), in which TNFR1 and other trans-was evident in the resistant cell line. This correlates with
TNFR1-Induced Apoptosis
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Figure 4. The Caspase-8 Containing Com-
plex II Does Not Contain TNFR1
(A) WT or I-kBmut HT1080 cells were stimu-
lated as described in Fig 2, but immunopre-
cipitations were performed using an anticas-
pase-8 antibody. Samples were analyzed by
Western blotting using antibodies to the indi-
cated proteins. Cleaved proteins are indi-
cated with filled arrowheads, while open ar-
rowheads point to the respective proteins
and their modified forms.
(B) Time course of Fas DISC formation in the
HT1080 I-kBmut cells after Fas ligand stimu-
lation and immunoprecipitation using either
an anti-Flag antibody or the anticaspase-8
antibody. Samples were analyzed by Western
blotting using antibodies to Fas, FADD, FLIPL,
and caspase-8.
membrane receptor such as transferrin receptor were Discussion
present. In agreement with results shown in Figure 2,
caspase-8 was not found in complex I. In contrast, com- Although the molecular mechanisms of TNF-induced
activation of prosurvival pathways (NF-B, JNK) haveplex II partitioned principally in the cytosolic fraction
(Figure 6B), although in this case, substantial amounts been reasonably well elucidated (Baud and Karin, 2001;
Devin et al., 2001), the principle deciding on whetherwere also detectable in the membrane fraction. This
may suggest that a proportion of complex II may be TNF signals cell survival or cell death remains largely
unknown. Our data now provide evidence that the deci-associated with cytoskeletal proteins.
sion is not made at the level of the rapidly formed com-
plex assembling around the ligand bound TNFR1 at the
plasma membrane. Commitment to cell death is slowComplex II Formation Requires FADD
As noted previously, there is convincing evidence that and is dependent on a complex that dissociates from
TNFR1 (complex II) and which is found mostly in theFADD is required for TNF-induced apoptosis (Juo et al.,
1999; Yeh et al., 1998). We therefore asked whether the cytoplasm.
The results presented in this paper are compatibledominant-negative version of FADD (FADD-DN) or the
absence of FADD would impair the formation of complex with the model outlined in Figure 8. TNFR1 stimulation
leads to the rapid assembly of a complex (complex I)II. As expected, HT1080-I-kBmut cells overexpressing
FADD-DN were resistant to TNF-induced apoptosis (Fig- comprising the receptor itself, TRADD, RIP1, TRAF2,
c-IAP1, and possibly other known (c-IAP2, FAN etc.) orure 7A). No or little RIP1 was found in anticaspase-8
immunoprecipitates after TNF treatment in FADD-DN yet unidentified proteins. Complex I is, however, devoid
of FADD and caspase-8. Complex I triggers the NF-Bcells (Figure 7B), indicating that RIP1 binding to cas-
pase-8 is dependent on the presence of FADD. Similar signaling pathway via recruitment of the IKK complex
(Zhang et al., 2000) whereas JNK is activated via TRAF2-data were obtained in the FADD-deficient Jurkat cell
line I2.1, in which RIP1 association with caspase-8 was mediated activation of MAP3-kinases (Chen and Goed-
del, 2002). Assembly of complex I occurs in lipid raftsseverely impaired, as evidenced by the absence of mod-
ified RIP1 (Figure 8C). Transfection with wt FADD re- (Legler et al., 2002) where posttranslational modifica-
tions of several complex-associated proteins are likelystored RIP1 association (Figure 7C). In contrast to com-
plex II, FADD-deficient and -reconstituted Jurkat I2.1 to occur. For example, complexed TNFR1, which in its
nonstimulated state exhibits an apparent molecularcells showed comparable amounts of RIP1 in complex I
(Figure 7D), demonstrating that RIP1 recruitment to mass of 48 kDa, forms molecular species with apparent
mw ranging from 48 kDa to up to 150 kDa. Also, up toTNFR1 is not dependent on the presence of FADD.
Taken together these data indicate that in complex II, 50% of TRADD present in complex I undergoes modifi-
cations that increase its molecular mass from 35 kDaprocaspase-8 interaction with RIP1 is dependent on
FADD. to approximately 44 kDa and 55 kDa. Finally, complex
Cell
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may act as a central platform for the recruitment and
activation of FADD, leading to the subsequent binding
of caspase-8.
After recruitment of FADD and caspase-8, the deci-
sion as to whether TNF acts to promote gene transcrip-
tion or apoptosis has to be made. Indeed, in contrast
to complex I, the composition of complex II in apoptosis-
resistant and sensitive cells differs. In resistant cells,
complex II comprises increased amounts of the two
antiapoptotic proteins c-IAP1 and FLIPL and the expres-
sion of which is regulated by the transcriptional activity
of NF-B (Micheau et al., 2001; Wang et al., 1998). Inhibi-
tion of the proapoptotic activity of caspase-8 is more
likely to occur through FLIPL, since enforced expression
of FLIP but not c-IAP1 potently blocks TNF-mediated
cell death (Micheau et al., 2001). Moreover, FLIP	/	 em-
bryonic fibroblasts are highly sensitive to TNF-induced
apoptosis and show rapid induction of caspase activi-
ties (Yeh et al., 2000). In keeping with this observation,
sixteen hrs after TNFR1 stimulation, complex II is devoid
of FLIPL in sensitive cells, while it contains increased
quantities of caspase-10. Caspase-8 is known to inter-
act with itself, caspase-10 and with FLIPs, although the
preferred interaction partner is FLIPL (Irmler et al., 1997;
Krueger et al., 2001; Wang et al., 2001). Thus, in cells
with high FLIPL content, caspase-10 has limited access
to caspase-8 within complex II, while in cells expressing
low quantities of FLIPL; high amounts of caspase-10 are
found associated with caspase-8. Whether FLIPL and
caspase-10 compete for the same site on caspase-8
Figure 5. Analysis of TNFR1-Induced Complex II in FLIP-Expressing
or whether FLIPL indirectly competes with caspase-10Cells
remains to be determined. Moreover, it is not known(A) Complex II was analyzed as in Figure 4 after an overnight incuba-
whether caspase-10 is an essential component in thetion with TNF in wt, I-kBmut, or I-kBmut cells stably transfected
proapoptotic complex II, since the role of caspase-10with FLIPL.
(B) Flag-tagged caspase-10, HA-tagged caspase-8, and increasing in TNF-mediated or in Fas-and TRAIL–mediated apopto-
quantities of VSV-FLIPL were overexpressed in 293 T cells and cas- sis is uncertain (Kischkel et al., 2001; Sprick et al., 2002).
pase-10 immunoprecipitates (anti-Flag) and cell extracts (CE) ana- FLIPL availability at the moment complex II is formed is
lyzed for the presence of caspase-10, caspase-8, and FLIPL. Aster- dependent on a signal previously triggered by complex I
isk, nonspecific band; filled arrowhead, cleaved proteins.
(Kreuz et al., 2001; Micheau et al., 2001). If NF-B-acti-
vation promotes the expression of FLIPL, the proapopto-
tic activity of caspase-8 is inhibited. In contrast, if
I-associated RIP1 migrates as a smear with apparent complex I-triggered NF-B activation is not productive,
mw ranging from 78 kDa to 120 kDa. the amount of available FLIPL will rapidly diminish and
Formation of complex I is transient since a large por- the proapoptotic activity of caspase-8 will not be
tion of TRADD, RIP1, and TRAF2 dissociate from TNFR1 stopped. Such a model predicts that FLIPL plays two
within an hour, at a time when TNFR1 starts to undergo important roles; on the one hand it regulates whether
endocytosis. Dissociation of TRADD was suggested to or not TNF triggers apoptosis, and on the other hand it
be dependent on TNFR1 endocytosis (Jones et al., is also able to act as a sensor for the fidelity of the signal
1999); although based on our data, endocytosis and emanating from complex I.
dissociation do not strictly correlate. Our data also do This model has interesting, more general implications
not reveal whether or not the extensive modifications as it predicts that the transcriptional activity of the
seen cause dissociation. In any case, after dissociation NF-B signaling pathway is controlled by (a) check-
from TNFR1, the DD of TRADD (and RIP1) previously point(s), similar to checkpoints controlling the integrity
engaged in the interaction with the DD of TNFR1 be- of cell cycle progression. This control mechanism is
comes available for interaction with other DD-containing triggered immediately after TNFR1 engagement but is
proteins. FADD is a likely interaction partner for TRADD, operational only a few hours later, at a time when the
since TRADD and FADD were previously shown to inter- success of the transcriptional activity of NF-B can be
act via their respective DD (Hsu et al., 1996; Thomas et assessed. Cells with defective NF-B signals (and thus
al., 2002; Varfolomeev et al., 1996). Although a RIP1- having low quantities of FLIP and other antiapoptotic
FADD-interaction was also described (Varfolomeev et proteins) will be eliminated through TNF-induced apo-
al., 1996), it is less likely to be of importance for complex ptosis.
II formation since TNFR1-induced apoptosis still pro- The formation of complex II may also explain the dif-
ceeds in RIP1-deficient Jurkat cells (Holler et al., 2000). ferent kinetics of apoptosis induced by TNFR1 and Fas.
Fas recruits FADD directly to the plasma membrane,Thus, similar to the DD of Fas, the DD of modified TRADD
TNFR1-Induced Apoptosis
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Figure 6. Complex I and Complex II Localize in Different Subcellular Compartments
(A) Subcellular fractionation and immunoprecipitation analysis of the TNFR1-induced proximal complex I. HT1080 I-kBmut cells were stimulated
as above and lysis was performed by use of a tight-fitting pestle in a dounce homogenizer (see Experimental Procedures). Soluble (S100)
and membrane-enriched (P100) were separated by ultracentrifugation and analyzed for the presence of TNFR1, RIP1, TRADD, and transferrin
receptor.
(B) Complex I was immunoprecipitated from the S100 and P100 fraction using Flag-TNF and analyzed by Western blotting.
(C) The subcellular localization of complex II was analyzed as in (B) by use of the anticaspase-8 antibody and Western blotting using antibodies
to RIP1, FADD, caspase-10, or caspase-8.
and subsequent activation of the two DED-containing FADD-deficient cells with FADD constructs carrying
these mutations severely impair Fas-induced apoptosis,upstream caspases is rapid and can occur within min-
utes. In contrast, TNFR1 is unable to recruit FADD di- but restore TNF-induced apoptosis (Thomas et al., 2002).
Moreover, overexpression of TRADD leads to FADD-rectly but instead recruits adaptor proteins, which upon
dissociation can bind FADD in a second step. Complex II dependent cell death (Yeh et al., 1998) placing FADD
downstream of TRADD. Recent results even suggestformation is clearly FADD-dependent, as demonstrated
using FADD-DN or FADD-deficient cells. Interestingly, that in promyelocytic cells, TRADD is able to trigger cell
death from within the nucleus (Morgan et al., 2002).point mutations in FADD, inhibiting the association with
Fas but not with TRADD or caspase-8, have been identi- Upstream caspases have to be brought in close prox-
imity for their activation (Boatright et al., 2003). Assem-fied (Thomas et al., 2002). Reconstitution of Jurkat
Figure 7. FADD Is Required for the Formation
of Complex II
(A) I-kBmut HT1080 cells overexpressing
(filled squares) or not (open squares) FADD-
DN were treated with increasing amounts of
TNF. Cell viability was quantified after 48 hr.
The inset shows the expression levels of
FADD in the two cell populations.
(B) Cells were stimulated for the indicated
time with TNF, and analysis of complex II for-
mation was performed by immunoprecipita-
tion as described Figure 5.
(C) Complex II and (D) complex I were ana-
lyzed in Jurkat FADD-deficient or FADD-defi-
cient cells reconstituted with FADD. Asterisk,
nonspecific band.
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Figure 8. Model of TNFR1-Mediated Apo-
ptosis
After binding of TNF to TNFR1, rapid recruit-
ment of TRADD, RIP1, and TRAF2 occurs
(complex I). Subsequently TNFR1, TRADD,
and RIP1 become modified () and dissoci-
ate from TNFR1. The liberated death domain
(DD) of TRADD (and/or RIP1) now binds to
FADD, resulting in caspase-8/10 recruitment
(forming complex II) and resulting in apopto-
sis. If NF-B activation triggered by complex
I is successful, cellular FLIPL levels are suffi-
ciently elevated to block apoptosis and cells
survive.
binant ligands (Fas ligand, TNF) were obtained from Apotech (Sanbly of death receptors upon ligand binding as well as
Diego).Apaf-1 complexes upon cytochrome c leads to the for-
mation of ideal platforms for caspase activation. It is
Cell Death and Viability Assayslikely that TRADD remains oligomerized upon dissocia- Fibrosarcoma HT1080 cells or transfectants derived from them
tion from TNFR1 and thus brings caspase-8/10 into (1.5 
 104 per well) were seeded in 96-well microtiter plates in
close proximity after recruitment of FADD. The TRADD- the presence of the indicated reagents for 48 hr and viability was
determined by the methylene blue colorimetric assay (Micheau etinduced type II complex is a soluble, cytoplasmic com-
al., 1999). In some experiments, the number of apoptotic cells wasplex that leads to caspase-8/10 activation. Cells defi-
determined by Hoechst staining. Caspase activity was assayed bycient in TRADD however, need to be studied to conclu-
incubating 10 l NP40 lysates with 100 l of a caspase reactionsively draw this conclusion. buffer (100 mM HEPES, [pH 7.0], 10% glycerol, 1 mM EDTA, 0.1%
CHAPS, and 1 mM dithiothreitol) containing 50 M of DEVD-AMC
Experimental Procedures (Apotech). The mixture was incubated for 60 min in an ELISA titer
plate and the fluorescence was measured using a Fluoroscan ELISA
Cell Culture reader (excitation 355 nm, emission 460 nm). Caspase-3 activity is
HT1080 (human fibrosarcoma) cell lines wt, I-Bmut, and the 293T expressed as the ratio of fluorescence increase relative to non-
human embryonic kidney cell line were cultured in Dulbecco’s modi- treated cells. Background was subtracted using the lysis buffer only.
fied Eagle’s medium Gibco BRL (Life Technologies, Gaithersburg, Values were normalized with respect to protein content.
MD) supplemented with 10% fetal calf serum (FCS), penicillin/strep-
tomycin (50 g/ml of each) and grown in 5% CO2 at 37C. HT1080 Western Blotting
wt or I-Bmut cells expressing FLIPL were described previously Cell lysates were prepared in lysis buffer (20 mM Tris-HCl [pH 7.4],
(Micheau et al., 2001). FADD-deficient Jurkat (I2.1) were maintained 150 mM NaCl, 10% glycerol, Nonidet NP40 0.2%, supplemented
in RPMI-1640 (Life Sciences, Basel, Switzerland) supplemented with with a protease inhibitor cocktail; Roche Biochemicals, Basel, Swit-
10% FCS and antibiotics. HT1080 expressing FADD-DN (aa 80-203) zerland). Cell debris and nuclei were removed by centrifugation at
or Jurkat I2.1 expressing wt FADD (1–209) stable cell populations 10,000 g for 10 min and the protein concentration was determined
were generated, essentially as described (Micheau et al., 2001), by by the Bradford assay (Pierce, Rockford, IL). Proteins were resolved
use of the viral vectors pBABE or pMSCV (Clontech), respectively. by SDS-PAGE, transferred to nitrocellulose membranes by elec-
troblotting and nonspecific binding sites were blocked by incubation
in TBS containing 0.5% Tween-20 and 5% (w/v) dry milk. Immu-Antibodies and Materials
noblot analyses were performed with the indicated antibodies.Rabbit polyclonal anti-TRAF2 (C20), anti-Nemo (FL-419), anti-Fas
Bound primary antibodies were visualized with horseradish peroxi-(C20), mouse anti-TRAF-1 (H3), anti-TNFR1 (H5), and anticaspase-8
dase-conjugated goat anti-rabbit-IgG, goat anti-rat-IgG, or goat anti-(C20) antibodies were purchased from Santa Cruz Biotechnology
mouse-IgG (Jackson Immunoresearch Laboratories, West Grove,(Santa Cruz, CA). Mouse anti-RIP1, anti-TRADD, and anti-FADD
PA) and ECL (Amersham, Freiburg, Germany). For TNFR1 complexwere from Transduction Lab (Lexington, KY). Mouse anticaspase-8
analysis, the horseradish peroxidase-conjugated goat anti-mouse(IgG 2b) and caspase-10 were from MBL (Naka-ku, Japan), antitrans-
IgG1, IgG2a, and IgG2b from Southern Biotechnology Associatesferrin receptor was from Zymed (San Francisco, CA). Anticaspase-8
(Birmingham, AL) were preferentially used.(IgG2a), anticaspase-3 and anticaspase-2 antibodies were from
Pharmingen (San Diego, CA), anti-FLIP (Dave II) was from Apotech
(San Diego), anti-IB from Biolabs (Beverly, MA). Anti-Flag (M2) TNFR1 Complex Analysis by Immunoprecipitation
The complexes initiated upon TNF stimulation were analyzed eitherantibody was from Sigma (St Louis, MO). Rabbit polyclonal antihu-
man active caspase-8 was kindly provided by T. Momoi (National by use of Flag-tagged TNF (Apotech) or Fc-TNF (Holler et al.,
2003) or by the use of anticaspase-8 antibodies (C20 from SantaInstitute of Neuroscience, Japan), anti-TNFR1 antagonistic antibody
(MAB 225) was from R&D. Anti-TNFR2 antagonistic antibody (UTR1) Cruz or Pharmingen). HT1080 cells, (5
 107 cells/ml) were stimulated
for the indicated times with 2 g TNF and lysed in 1 ml lysis bufferwas a gift from Dr. Brockhaus (Hoffmann La Roche). Human recom-
TNFR1-Induced Apoptosis
189
(20 mM Tris-HCl, [pH 7.4], 150 mM NaCl, 0.2% Nonidet P40, 10% and Salvesen, G.S. (2003). A unified model for apical caspase activa-
tion. Mol. Cell 11, 529–541.glycerol, and complete protease inhibitor cocktail) for 15 min on
ice. Lysates were precleared with 20 l Sepharose-6B (Sigma- Bodmer, J.L., Schneider, P., and Tschopp, J. (2002). The molecular
Aldrich) for 0.5–2 hr at 4C and immunoprecipitated with 20l protein architecture of the TNF superfamily. Trends Biochem. Sci. 27, 19–26.
G-Sepharose CL-4B (Amersham) for 4 hr to overnight at 4C with
Chen, G., and Goeddel, D.V. (2002). TNF-R1 signaling: a beautiful
2 g anti-Flag M2 or 2 g anticaspase-8. Beads were recovered by
pathway. Science 296, 1634–1635.
centrifugation and washed four times with 500 l of lysis buffer
Devin, A., Lin, Y., Yamaoka, S., Li, Z., Karin, M., and Liu, Z. (2001). Thebefore analysis by SDS–PAGE and Western blotting.
alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-
dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1Coimmunoprecipitation Experiments
in response to TNF. Mol. Cell. Biol. 21, 3986–3994.293T cells were plated overnight in 10 cm dishes and transfected
Duan, H., and Dixit, V.M. (1997). RAIDD is a new death adaptorwith the indicated pCRII-based expression vectors for HA-tagged
molecule. Nature 385, 86–89.caspase-8, VSV-tagged FLIPL, as previously described (Thome et al.,
1997) or a FLAG-tagged caspase-10 for 24 hr. Cells were collected, Holler, N., Tardivel, A., Kovacsovics-Bankowski, M., Hertig, S.,
washed in PBS, and lysed in a buffer containing 0.1% Nonidet-P40, Gaide, O., Martinon, F., Tinel, A., Deperthes, D., Calderara, S.,
50 mM Tris [pH 7.8], 150 mM NaCl, 5 mM EDTA, and protease Schulthess, T., et al. (2003). Two adjacent trimeric Fas ligands are
inhibitor cocktail. Complete lysis was ensured by three subsequent required for Fas signaling and formation of a death-inducing signal-
quick steps of freezing-thawing. Preclearing was achieved with ing complex. Mol. Cell. Biol. 23, 1428–1440.
20 l Sepharose 6B for 1 hr, and lysates were incubated overnight Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti,
at 4C in the presence of protein G Sepharose and 1 g anti-FLAG S., Bodmer, J.L., Schneider, P., Seed, B., and Tschopp, J. (2000). Fas
antibody before analysis by Western blotting. triggers an alternative, caspase-8-independent cell death pathway
using the kinase RIP as effector molecule. Nat. Immunol. 1, 489–495.
Subcellular Fractionation
Hsu, H., Shu, H.B., Pan, M.G., and Goeddel, D.V. (1996). TRADD-
Cells were stimulated or not with TNF, washed twice in cold PBS,
TRAF2 and TRADD-FADD interactions define two distinct TNF re-
and resuspended in 1 ml homogenization buffer (250 mM sucrose,
ceptor 1 signal transduction pathways. Cell 84, 299–308.
20 mM Tris-Hcl [pH 7.4], 1 mM MgCl2, 1 mM MnCl2, plus complete
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K.,protease inhibitor cocktail; Roche Biochemicals) for 20 min on ice.
Steiner, V., Bodmer, J.L., Schroter, M., Burns, K., Mattmann, C., etCells were disrupted with 15 strokes of a tight-fitting pestle in a
al. (1997). Inhibition of death receptor signals by cellular FLIP. Naturedounce homogenizer. Nuclei and unbroken cells were removed by
388, 190–195.low-speed centrifugation (1000 g for 10 min at 4C) and homoge-
nates were centrifuged at 100,000 g for 1 hr at 4C. The pellets Jones, S.J., Ledgerwood, E.C., Prins, J.B., Galbraith, J., Johnson,
containing cellular membranes were resuspended in 10 mM Tris- D.R., Pober, J.S., and Bradley, J.R. (1999). TNF recruits TRADD to
HCl [pH 7.4], 150 mM NaCl, and 0.2% NP40. Both fractions were the plasma membrane but not the trans-golgi network, the principal
used for further immunoprecipitation as described above. subcellular location of TNF-R1. J. Immunol. 162, 1042–1048.
Juo, P., Kuo, C.J., Yuan, J., and Blenis, J. (1998). Essential require-
Size Exclusion Chromatography ment for caspase-8/FLICE in the initiation of the Fas-induced apo-
HT1080 I-kBmut cells (108) were stimulated with 100 ng/ml TNF ptotic cascade. Curr. Biol. 8, 1001–1008.
for 5 or 960 min, washed twice in cold phosphate-buffered saline, Juo, P., Woo, M.S., Kuo, C.J., Signorelli, P., Biemann, H.P., Hannun,
and lysed in CHAPS-containing lysis buffer (14 mM CHAPS, 150 Y.A., and Blenis, J. (1999). FADD is required for multiple signaling
mM NaCl, and 20 mM Tris-Hcl [pH 7.4]) plus complete protease events downstream of the receptor Fas. Cell Growth Differ. 10,
inhibitors. Lysates were loaded onto a Superdex-200 HR10/30 col- 797–804.
umn previously equilibrated in CHAPS lysis buffer. Proteins were
Karin, M., and Lin, A. (2002). NF-kappaB at the crossroads of lifeeluted at 1 ml/min. Fractions (1 ml) were maintained at 4C and
and death. Nat. Immunol. 3, 221–227.precipitated using chloroform/methanol. Samples were analyzed
Kischkel, F.C., Lawrence, D.A., Tinel, A., LeBlanc, H., Virmani, A.,by Western blotting for TNFR1, RIP1, TRADD, TRAF2, IKK, IKK,
Schow, P., Gazdar, A., Blenis, J., Arnott, D., and Ashkenazi, A. (2001).caspase-8, caspase-3, caspase-10, FADD, and Fas using appro-
Death receptor recruitment of endogenous caspase-10 and apopto-priate antibodies, and apparent molecular weight evaluated after
sis initiation in the absence of caspase-8. J. Biol. Chem. 276, 46639–column calibration with standard proteins: thyroglobulin (669 kDa),
46646.ferritin (440 kDa), aldolase (158 kDa), bovine serum albumin (67 kDa),
ovalbumin (43 kDa), chymotrypsinogen A (25 kDa), and ribonuclease Krammer, P.H. (2000). CD95s deadly mission in the immune system.
A (13.7 kDa). Nature 407, 789–795.
Kreuz, S., Siegmund, D., Scheurich, P., and Wajant, H. (2001). NF-
Acknowledgments kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhib-
itor of death receptor signaling. Mol. Cell. Biol. 21, 3964–3973.
This work was supported by grants of the Swiss National Science
Krueger, A., Baumann, S., Krammer, P.H., and Kirchhoff, S. (2001).Foundation (to J.T.). We thank Helen Everett, Margot Thome, Kim
FLICE-inhibitory proteins: regulators of death receptor-mediatedBurns, Pascal Schneider, Ralph Budd, and the whole Tschopp group
apoptosis. Mol. Cell. Biol. 21, 8247–8254.for stimulating discussions.
Lassus, P., Opitz-Araya, X., and Lazebnik, Y. (2002). Requirement
for caspase-2 in stress-induced apoptosis before mitochondrial per-Received: October 30, 2002
meabilization. Science 297, 1352–1354.Revised: June 17, 2003
Legler, D.F., Micheau, O., Doucey, M.A., Tschopp, J., and Bron, C.Accepted: June 23, 2003
(2003). Recruitment of TNF Receptor 1 to lipid rafts is essential forPublished: July 24, 2003
TNFa-mediated NF-kB activation. Immunity 18, 655–664.
References Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K., and Tschopp,
J. (2001). NF-kappaB signals induce the expression of c-FLIP. Mol.
Cell. Biol. 21, 5299–5305.Ashkenazi, A., and Dixit, V.M. (1998). Death receptors: signaling and
modulation. Science 281, 1305–1308. Micheau, O., Solary, E., Hammann, A., and Dimanche-Boitrel, M.T.
(1999). Fas ligand-independent, FADD-mediated activation of theBaud, V., and Karin, M. (2001). Signal transduction by tumor necrosis
Fas death pathway by anticancer drugs. J. Biol. Chem. 274, 7987–factor and its relatives. Trends Cell Biol. 11, 372–377.
7992.Boatright, K.M., Renatus, M., Scott, F.L., Sperandio, S., Shin, H.,
Pedersen, I.M., Ricci, J.E., Edris, W.A., Sutherlin, D.P., Green, D.R., Morgan, M., Thorburn, J., Pandolfi, P.P., and Thorburn, A. (2002).
Cell
190
Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via
different mechanisms. J. Cell Biol. 157, 975–984.
Poyet, J.L., Srinivasula, S.M., Lin, J.H., Fernandes-Alnemri, T.,
Yamaoka, S., Tsichlis, P.N., and Alnemri, E.S. (2000). Activation of
the Ikappa B kinases by RIP via IKKgamma/NEMO-mediated oligo-
merization. J. Biol. Chem. 275, 37966–37977.
Rath, P.C., and Aggarwal, B.B. (1999). TNF-induced signaling in
apoptosis. J. Clin. Immunol. 19, 350–364.
Scaffidi, C., Kirchhoff, S., Krammer, P.H., and Peter, M.E. (1999).
Apoptosis signaling in lymphocytes. Curr. Opin. Immunol. 11,
277–285.
Schutze, S., Machleidt, T., Adam, D., Schwandner, R., Wiegmann,
K., Kruse, M.L., Heinrich, M., Wickel, M., and Kronke, M. (1999).
Inhibition of receptor internalization by monodansylcadaverine se-
lectively blocks p55 tumor necrosis factor receptor death domain
signaling. J. Biol. Chem. 274, 10203–10212.
Sprick, M.R., Rieser, E., Stahl, H., Grosse-Wilde, A., Weigand, M.A.,
and Walczak, H. (2002). Caspase-10 is recruited to and activated
at the native TRAIL and CD95 death-inducing signalling complexes
in a FADD-dependent manner but can not functionally substitute
caspase-8. EMBO J. 21, 4520–4530.
Thomas, L.R., Stillman, D.J., and Thorburn, A. (2002). Regulation
of FADD death domain interactions by the death effector domain
identified by a modified reverse two-hybrid screen. J. Biol. Chem.
277, 34343–34348.
Thome, M., Schneider, P., Hofmann, K., Fickenscher, H., Meinl, E.,
Neipel, F., Mattmann, C., Burns, K., Bodmer, J.L., Schroter, M., et
al. (1997). Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis
induced by death receptors. Nature 386, 517–521.
Tschopp, J., Irmler, M., and Thome, M. (1998). Inhibition of Fas death
signals by FLIPs. Curr. Opin. Immunol. 10, 552–558.
Varfolomeev, E.E., Boldin, M.P., Goncharov, T.M., and Wallach, D.
(1996). A potential mechanism Of cross-talk between the P55 tumor
necrosis factor receptor and Fas/Apo1-proteins binding to the death
domains of the two receptors also bind to each other. J. Exp. Med.
183, 1271–1275.
Wallach, D., Varfolomeev, E.E., Malinin, N.L., Goltsev, Y.V., Kova-
lenko, A.V., and Boldin, M.P. (1999). Tumor necrosis factor receptor
and Fas signaling mechanisms. Annu. Rev. Immunol. 17, 331–367.
Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V., and Bald-
win, A.S., Jr. (1998). NF-kappaB antiapoptosis: induction of TRAF1
and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activa-
tion. Science 281, 1680–1683.
Wang, J., Chun, H.J., Wong, W., Spencer, D.M., and Lenardo, M.J.
(2001). Caspase-10 is an initiator caspase in death receptor signal-
ing. Proc. Natl. Acad. Sci. USA 98, 13884–13888.
Yeh, W.C., Itie, A., Elia, A.J., Ng, M., Shu, H.B., Wakeham, A., Mirtsos,
C., Suzuki, N., Bonnard, M., Goeddel, D.V., and Mak, T.W. (2000).
Requirement for Casper (c-FLIP) in regulation of death receptor-
induced apoptosis and embryonic development. Immunity 12,
633–642.
Yeh, W.C., Pompa, J.L., McCurrach, M.E., Shu, H.B., Elia, A.J., Shahi-
nian, A., Ng, M., Wakeham, A., Khoo, W., Mitchell, K., et al. (1998).
FADD: essential for embryo development and signaling from some,
but not all, inducers of apoptosis. Science 279, 1954–1958.
Zhang, S.Q., Kovalenko, A., Cantarella, G., and Wallach, D. (2000).
Recruitment of the IKK signalosome to the p55 TNF receptor: RIP
and A20 bind to NEMO (IKKgamma) upon receptor stimulation. Im-
munity 12, 301–311.
